Trial
NCT00334685
[S,S]-Reboxetine Add-On Trial
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Pain
Intervention
[S,S]-Reboxetine + Pregabalin
Why stopped
The Data Monitoring Committee terminated the study on the basis of futility (insufficient clinical response).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-16